Ending the HIV Epidemic Funding

Content From: Office of Infectious Disease and HIV/AIDS Policy, HHSUpdated: April 05, 202214 min read

Topics

President Biden Requests $850 Million in Fiscal Year 2023 to Support the Ending the HIV Epidemic in the U.S. Initiative

On March 28, 2022, the White House published President Joe Biden’s fiscal year 2023 (FY2023) budget request, which includes $850 million in funding across CDC, HRSA, IHS, and NIH to continue to support the fourth year of the Ending the HIV Epidemic in the U.S. (EHE) initiative. This reflects an increase of $377 million above FY2022 enacted funding.

The President’s FY2023 budget proposal places his commitment to ending the HIV epidemic in the broader context of the National HIV/AIDS Strategy for the United States (2022–2025). The budget states, “To meet this ambitious target and ultimately end the HIV/AIDS epidemic in the United States, the Budget includes $850 million across HHS to aggressively reduce new HIV cases by increasing access to HIV prevention and care programs and ensuring equitable access to support services.”

The specific funding amounts proposed by agency are:

  • $310 million for the Centers for Disease Control and Prevention (CDC)
  • $462 million for the Health Resources and Services Administration (HRSA):
    • $290 million to deliver HIV care through the Ryan White HIV/AIDS Program (RWHAP)
    • $172 million to provide HIV testing, linkage to care, and prescription of HIV pre-exposure prophylaxis (PrEP) and associated medical costs through the Health Center Program
  • $52 million to the Indian Health Service (IHS) for an initiative to treat or reduce the transmission of HIV and HCV.
  • $26 million for the National Institutes of Health (NIH) for implementation research projects in the EHE jurisdictions.

Congress is now considering the President’s request as part of its responsibility to complete the annual federal budget and appropriations process. Additional details about the EHE funding requests can be found in the HHS Budget in Brief and individual agency budget documents (CDC, HRSA, IHS, NIH).

Fiscal Year 2022 HHS Budget Resources for the Ending the HIV Epidemic Initiative

In March 2022, Congress passed and President Biden signed the fiscal year 2022 (FY2022) federal budget for October 1, 2021–September 30, 2022, which included $473.2 million for implementation of the Ending the HIV Epidemic in the U.S. (EHE) initiative. These funds included:

  • $195 million for CDC to reduce new HIV infections.
  • $247 million for the HRSA:
    • $125 million to deliver HIV care through the Ryan White HIV/AIDS Program  
    • $122 million to provide HIV testing, linkage to care, and prescription of HIV pre-exposure prophylaxis (PrEP) and associated medical costs through the Health Center Program
  • $5 million to the IHS for an initiative to treat or reduce the transmission of HIV and HCV.
  • $26 million for the NIH for implementation research projects in the EHE jurisdictions.

The FY2022 total was less than the $670 million requested in President Biden’s FY2022 budget request.

Fiscal Year 2021 HHS Budget Resources for the Ending the HIV Epidemic Initiative

In December 2020, Congress passed and the President signed the fiscal year 2021 (FY21) federal budget, which included $404.5 million for implementation of the EHE initiative:

  • $175 million for the Centers for Disease Control and Prevention (CDC) to reduce new HIV infections.
  • $208.5 million for the Health Resources and Services Administration (HRSA), allocated as $105 million to deliver HIV care through the Ryan White HIV/AIDS Program (RWHAP); $102 million to provide HIV testing, linkage to care, and prescription of pre-exposure prophylaxis (PrEP) and associated medical costs through the Health Centers program; and $1.5 million for rural HIV technical assistance through Bureau of Primary Health Care-funded Primary Care Associations.
  • $5 million to the Indian Health Service (IHS) for an initiative to treat or reduce the transmission of HIV and HCV.
  • $16 million for the National Institutes of Health (NIH) for evaluation activities to identify effective interventions to treat and prevent HIV.

With those resources, the following FY21 funding awards were made:

  • HRSA awarded nearly $99 million to 61 RWHAP recipients to link people with HIV to essential HIV care and treatment and support services, as well as to provide workforce training and technical assistance. This included more than $87 million to 39 metropolitan areas and eight states, which are Ryan White HIV/AIDS Program Parts A and B jurisdictions, to enable recipients to implement strategies, interventions, approaches, and core medical and support services to reduce new HIV infections in the U.S. HRSA also awarded $3 million to 12 RWHAP Part F AIDS Education and Training Centers Program recipients to provide workforce capacity development and technical assistance to the identified jurisdictions. In addition, HRSA awarded $8 million to two organizations to continue providing technical assistance and systems coordination services to the 47 RWHAP A and B jurisdictions. The awards were made in March 2021. View a list of the fiscal year 2021 Ryan White HIV/AIDS Program Ending the HIV Epidemic award recipients.
  • HRSA awarded over $48 million to 271 health centers across 26 states, Puerto Rico, and the District of Columbia to expand HIV prevention and treatment, including pre-exposure prophylaxis (PrEP) related services, outreach, and care coordination. These awards build upon FY2020 HRSA Health Center Program EHE Primary Care HIV Prevention (PCHP) awards by funding additional health centers in the EHE priority jurisdictions. The FY21 awards included nearly $38 million in funding to 108 HRSA-supported health centers not funded in FY 2020, and over $10 million in additional resources to expand the efforts of the 163 HRSA-supported health centers who received FY 2020 PCHP funding. Awarded health centers are using the funding to conduct outreach and HIV testing, expand their workforce to increase access to and use of PrEP, and connect individuals who test positive for HIV to treatment. Health centers receiving these funds are encouraged to partner more closely with community organizations such as RWHAP-funded organizations and health departments to facilitate referrals to the health center for HIV testing and prevention services. Read more about these awards. See a list of the FY 2021 PCHP award recipients.  
  • The National Institutes of Health awarded approximately $16 million to support implementation science research to advance the goals of the EHE initiative. Approximately $15.2 million of the funds were issued to NIH’s 17 Centers for AIDS Research (CFARs) and to the National Institute of Mental Health’s five AIDS Research Centers (ARCs) for 36 new one-year awards. The projects are a collaborative effort of CFAR/ARC investigators, local implementing partners, and community groups in the EHE priority jurisdictions and will investigate how to best deliver evidence-based interventions and services for populations that face a disproportionate risk of HIV, including Black and Latinx populations. Fifteen awards were made to aid in the development of research projects to address needs identified by EHE teams working in local communities. The teams will leverage existing, effective tools to diagnose, prevent and treat HIV in EHE’s priority communities. An additional 21 awards were made to support projects that address social and structural determinants of HIV using intersectional framework. Intersectionality provides a lens to examine how multiple disadvantages come together to create systematic differences in HIV testing, prevention, treatment, and care, specifically in communities substantially impacted by HIV. The remaining $800,000 was awarded to support the final year of two-year awards made in 2020Read more about these awards. View a list of the recipients.
  • CDC awarded $117 million to state and local health departments in the 57 EHE jurisdictions to continue advancing innovation and health equity in the federal initiative to end HIV. The awards build on initial investments made in CDC’s FY20 Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States cooperative agreements (see below) and will be used to reduce health disparities related to the four EHE strategies: Prevent, Diagnose, Treat and Respond. The second year of funding will help rebuild and expand HIV prevention and treatment efforts as the U.S. recovers from COVID-19. The awards included $11 million for 19 communities to scale up quality HIV prevention services in sexually transmitted disease clinics. Read more about these awards.

Fiscal Year 2020 Budget Allocated Additional Resources for Ending the HIV Epidemic

In December 2019, Congress passed, and the President signed into law, a $1.4 trillion spending package for Fiscal Year (FY) 2020. The legislation appropriated $267 million for EHE activities, including:

  • $140 million in new funding for the CDC’s Division of HIV/AIDS Prevention to expand the use of PrEP, develop approaches to better detect and respond to clusters of HIV cases, and invest in core HIV prevention programs at State and local health departments to provide the foundational infrastructure for the initiative.
  • $70 million in additional funding for HRSA’s RWHAP to expand access to HIV treatment and antiretroviral therapy for those newly diagnosed with HIV.
  • $50 million in continued funding for HRSA's Bureau of Primary Health Care to support outreach, testing, care coordination, and HIV prevention services, including the use of PrEP through community health centers.
  • $1 million for HRSA to support technical assistance in rural states as part of the EHE.
  • $6 million for NIH for targeted HIV research that includes continuing and expanding EHE-focused implementation research and disseminating best practices.

These increases are in addition to core CDC and HRSA appropriations for HIV prevention, care, treatment, and research programs that received full funding. NIH also received an additional $25 million to support its existing HIV/AIDS research portfolio, which is not specific to the initiative, but supports the highest priority areas of scientific research necessary to end HIV and improve health outcomes for persons affected.

However, $25 million requested for the Indian Health Service EHE activities was not appropriated.

To date, the following FY20 funding opportunity announcements and awards have been made:

  • Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States: In July 2020, CDC awarded $109 million to state and local health departments to support the EHE Phase I jurisdictions in implementing the comprehensive Ending the HIV Epidemic plans that each one developed, informed by consultations with diverse stakeholders and community-level input. The funding awards are part of a five-year funding program, which will help state, local, and territorial health departments scale up four strategies that can end the epidemic: diagnosing all people with HIV as early as possible; treating people with HIV rapidly and effectively to reach sustained viral suppression; preventing new HIV transmissions with proven interventions, including PrEP and syringe services programs; and responding quickly to potential outbreaks to get needed prevention and treatment services to people who need them. As part of this effort, CDC also awarded a total of $3 million to seven state and local health departments to scale up quality HIV prevention services in STD clinics. View the table of awards by jurisdiction (PDF, 161 KB). Read more about the funding.
  • HRSA awarded approximately $63 million to 60 Ryan White HIV/AIDS Program recipients to link people with HIV to essential HIV care and treatment and support services, as well as to provide workforce training and technical assistance: In February 2020, HRSA announced awards that included more than $55 million to 39 metropolitan areas and eight states, which are RWHAP Parts A and B jurisdictions, to enable recipients to implement strategies, interventions, approaches, and core medical and support services to reduce new HIV infections in the U.S. In addition, HRSA awarded approximately $3 million to 11 RWHAP Part F AIDS Education and Training Centers Program recipients to provide workforce capacity development and technical assistance to the identified jurisdictions. HRSA also awarded $5 million to two organizations to provide technical assistance and systems coordination services to the 47 Parts A and B jurisdictions. The funding announcements were issued in summer 2019.
  • HRSA awarded nearly $54 million to 195 health centers with service delivery sites in geographic locations identified by the EHE initiative: Also in February 2020, HRSA announced this first-of-its-kind program that emphasizes outreach, HIV testing, partnerships, and workforce expansion to increase access to and use of PrEP, as well as linking individuals who test positive for HIV to treatment. HRSA’s Primary Care HIV Prevention (PCHP) funding opportunity was released in the fall of 2019 with applications due from eligible health centers in late December. Supporting both the Diagnose and Prevent pillars of EHE, health centers will use the funding to expand HIV prevention services that decrease the risk of HIV transmission, focusing on supporting access to and use of PrEP, as well expanding HIV testing in primary care settings and linking those who test positive to HIV care and treatment.
  • NIH awarded $10 million to support implementation science research to advance the goals of EHE. In September 2020, NIH announced that it had awarded approximately $10 million in supplemental funds to 17 of its Centers for AIDS Research (CFARs) and AIDS Research Centers (ARCs), that are collaborating with partners in local communities on research to determine how best to leverage existing, highly effective tools to diagnose, prevent and treat HIV. Read more about this funding and view a list of the awards.

FY19 Resources Supported Preliminary Activities

HHS allocated some FY2019 resources, including $33 million from the Minority HIV/AIDS Fund (MHAF), to activities that supported jurisdictions and other stakeholders in initiating some preliminary EHE activities. This helped galvanize key stakeholders and community members following the initiative’s announcement, resulting in new ideas and collaborations focused on the goal of ending the HIV epidemic. The activities to which these FY2019 resources were allocated include:

  • Launch of Ready, Set, PrEP: On December 3, 2019, HHS launched Ready, Set, PrEP, a national program that makes medications for PrEP, taken daily to prevent HIV, available at no cost to people without prescription drug insurance coverage. To qualify for the program, participants must test negative for HIV, receive a valid prescription from a healthcare provider, and not have prescription drug coverage. PrEP is a critical component of the Prevent pillar of EHE. FY2019 resources were awarded to support the process of patient verification, enrollment, distribution of the prescriptions, and a consumer and provider awareness campaign.
  • Pilot Site Activities: HHS allocated MHAF resources to support four “jumpstart sites.” The Assistant Secretary for Health announced in July the allocation of resources to three jurisdictions to jumpstart activities under EHE. The funds—$1.5 million each to Baltimore City, Md.; DeKalb County, Ga.; and East Baton Rouge Parish, La.—are supporting the jurisdictions’ health departments to move swiftly to implement key parts of the initiative, including providing treatment for those living with HIV, increasing HIV testing, and expanding preventative services, including PrEP. Read about East Baton Rouge’s innovative efforts to expand HIV diagnosis, treatment, and prevention. In addition, IHS awarded $1.5 million of MHAF resources to the Cherokee Nation Health Service to launch an HIV pilot project to begin implementing and evaluating some key foundational activities to help accelerate progress toward ending the HIV epidemic in Indian Country.
  • Rapid Planning Processes in 57 Phase I Jurisdictions: In June, CDC announced a Notice of Funding Opportunity, PS19-1906: Strategic Partnerships and Planning to Support Ending the HIV Epidemic in the United States, to support eligible state and local health departments to conduct a rapid planning process that engages the community, HIV planning bodies, HIV prevention and care providers, and other partners in aligning resources and activities to develop jurisdictional plans to end the HIV epidemic in the 57 jurisdictions prioritized in Phase I of the initiative. Then, in September 2019, HHS announced that $12 million of the Minority HIV/AIDS Fund was awarded to 32 CDC-funded state and local health departments to develop those comprehensive EHE plans that are tailored by and for each of the 57 jurisdictions prioritized in Phase I of the initiative. In addition, CDC awarded $1.5 million to NASTAD to provide technical assistance to the jurisdictions in developing and implementing those plans. Draft plans from each jurisdiction were submitted at the end of December 2019. Feedback on the plans was shared with jurisdictions by the end of March 2020.
  • Efforts to End HIV in Ryan White Part A Jurisdictions: In June, HRSA awarded approximately $1 million to 10 metropolitan areas that are designated Part A jurisdictions under the RWHAP to support technical assistance that enhances efforts to end the HIV epidemic. Eight of those 10 jurisdictions are Phase I priority jurisdictions. Based on the awarded jurisdictions’ needs, activities under this initiative include community engagement, enhancing core medical and support services, infrastructure support, and information dissemination efforts.
  • Targeted Implementation Research Projects: In September, NIH awarded approximately $11.3 million to 17 NIH-funded Centers for AIDS Research (CFARs) and six AIDS Research Centers (ARCs) funded by the National Institute of Mental Health (NIMH) to identify and design targeted implementation science research projects that address at least one of the key pillars of the initiative and support local initiative plans. As part of this effort, the CFARs and ARCs will build on existing relationships with local health authorities, community-based groups, and other HHS agencies involved in EHE. A total of 65 awards were made, funding research in 36 of the 48 counties and five of the seven states with a high rural burden, as well as in Washington, D.C., and Puerto Rico. The supplements were funded with NIH resources as well as $1.5 million in MHAF resources. View a list of awardees.
  • Strengthening Capacity in Tribal Communities: IHS awarded $2.4 million to nine Tribal Epidemiology Centers to support American Indian and Alaska Native communities in reducing new HIV infections and relevant co-morbidities, specifically hepatitis C and sexually transmitted infections. Resources from the FY2019 MHAF supported these awards. The Tribal Epidemiology Centers will participate in regional- and national-level coordination, provide technical assistance and disease surveillance support to communities, and support the development of community plans to end the HIV epidemic throughout Indian Country. Read the announcement about the funding awards and view a list of the recipients.
  • Deployment of PACE Officers: Teams of U.S. Public Health Service (USPHS) commissioned corps officers have been strategically deployed to HHS Regions 4, 6, and 9 to support the implementation of EHE in three HHS regions. The officers are deployed as part of the Prevention through Active Community Engagement (PACE) program of the Office of the Assistant Secretary for Health. This component of the larger PACE program is funded with resources from the MHAF. The two PACE officers in each region serve as public health educators about the initiative and its strategies, opportunities, and developments. They also engage with community stakeholders at various public forums to raise awareness of effective evidence-based HIV prevention, testing, and care interventions.
    Read the announcement.

Visit the EHE Timeline for highlights of other activities that have taken place since the initiative began.